Medicine for HIV AIDS, hepatitis c virus infection, cancer treatment

Treatment for viral diseases:

  • Flu virus
  • Encephalitis
  • Herpes I & II
  • Hepatitis B
  • Hepatitis C
  • HTLV (human T-cell leukemia virus)
  • HIV I & II
  • HBV (hepstein bar virus)


a) Flu prevention and treatment
For the prevention of flu-virus illness:
1/5cc of Di-Sancor diluted with clean water, taken orally in the morning 30 minutes before meal; will activate the immune system and provide protection against flu-virus infection.
Treatment course: five consecutive days.
If risk of infection persists, continue treatment while flu epidemic continues.

b) Encephalitis:
tick transmitted encephalitis virus can be prevented and/or treated with Di-Sancor diluted 1:5 and 1:1 with water, respectively. Treatment should continue for two weeks and patient evaluated by a health professional.

c) Herpes I and II:
Herpes of oral cavity, lips and eyes can be treated topically with a cotton swab soaked with Di-Sancor. Internal (oral) treatment may also be used.
For treatment of genital herpes oral treatment is preferable to topical: One vial of Di-Sancor diluted in 30cc water, 30 minutes before morning meal.
Treatment should continue until blisters have dissappeared.

d) Hepatitis B and C:
individuals that have tested positive HEP B/C, use the full 5.0cc of Di-Sancor (one vial) diluted in 30cc of sterile water, 30 minutes before morning meal for 20 consecutive days.
Treatment should continue until patients test negative for Hepatitis B/C.

e) Human T-cell leukemia virus (HTLV):
Leukemia with viral etiology is treatable with Di-Sancor:
one vial diluted to 30cc of water, every day, 30 minutes before morning meal. Treatment should continue 30 days followed by clinical evaluation of disease status.
Advanced T-cell leukemia may be treated by intravenous administration of Di-Sancor under medical supervision and advise.

F) Aquired Immunodeficiency Disease (AID):
AIDS patients that have tested positive for HIV-1/2 are treated with Di-Sancor: one vial daily 30 minutes before morning meal. Treatment efficancy should be monitored by the decrease of viral load. Decrease in HIV-load should be evident after 30 days of treatment. Treatment should continue until viral load becomes undetectable.
In patients with high viral load and clinical symptoms of AIDS may be treated intravenously under medical supervision.